COHANCE LIFESCIENCES LTD.
|
Market Cap.(`)
|
27569.38 Cr.
|
P/BV
|
13.94
|
Book Value (`)
|
77.71
|
|
52 Week High/Low ( ` )
|
1360/598
|
FV/ML
|
1/1
|
P/E(X)
|
91.81
|
|
Book Closure
|
09/08/2024
|
EPS (`)
|
11.80
|
Div Yield (%)
|
0.00
|
(` in Crs.)
You can view the
Consolidated
Cash Flow
for the last 5 years.
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | 405.67 | 559.73 | 667.59 | 467.67 | 404.51 |
| | | | | | |
| Net CashFlow From Operating Activities | 358.48 | 450.91 | 330.00 | 383.44 | 415.95 |
| Net Cash Used In Investing Activities | -362.25 | -194.84 | -136.21 | -311.40 | -421.53 |
| Net Cash Used From Financing Activities | -13.80 | -235.83 | -156.41 | -76.55 | 6.37 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | -17.57 | 20.24 | 37.38 | -4.51 | 0.79 |
| Cash And Cash Equivalents Begin of Year | 64.80 | 44.56 | 7.18 | 11.70 | 10.90 |
| Cash And Cash Equivalents End Of Year | 47.23 | 64.80 | 44.56 | 7.18 | 11.70 |